Henan Lingrui Pharmaceutical Co., Ltd. (600285.SS)
CNY 22.31
(5.19%)
CNY 22.31
(5.19%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 813.42 Million | 834.9 Million | 845.68 Million | 450.52 Million | 450.15 Million | 436.24 Million |
| Net Income | 568.11 Million | 465.33 Million | 362.49 Million | 324.38 Million | 293.14 Million | 245.76 Million |
| Depreciation & Amortization | 77.62 Million | 76.24 Million | 72.79 Million | 68.46 Million | 67.57 Million | 68.39 Million |
| Deferred income taxes | -23.09 Million | -33.58 Million | -16.51 Million | -19.07 Million | -4.23 Million | 4.27 Million |
| Stock-based compensation | 14.07 Million | 37.61 Million | - | - | - | - |
| Change in working capital | 158.06 Million | 309.57 Million | 374.85 Million | 60.88 Million | 60.79 Million | 83.48 Million |
| Other non-cash items | 6.37 Million | -20.28 Million | 35.53 Million | -3.19 Million | 28.64 Million | 38.6 Million |
| Investing Cash Flow | -229.7 Million | -83.81 Million | -545.79 Million | 11.87 Million | -212.24 Million | 118.17 Million |
| Investments in PPE | -21.19 Million | -26.99 Million | -76.9 Million | -71.82 Million | -59.03 Million | -52.14 Million |
| Acquisitions | 10.15 Million | 12.22 Million | 474.09 Thousand | 203.82 Thousand | 840.56 Thousand | -66.66 Million |
| Investment purchases | -30.05 Million | -58.94 Thousand | -30.33 Million | -60.5 Million | -26.17 Million | -42.62 Million |
| Sales/Maturities of investments | 21.39 Million | 14.03 Million | 13.97 Million | 16.66 Million | 14.22 Million | 34.46 Million |
| Other Investing Activities | -210 Million | -83.01 Million | -452.99 Million | 127.33 Million | -142.09 Million | 245.13 Million |
| Financing Cash Flow | -272.73 Million | -373.08 Million | -230.94 Million | -306.2 Million | -277.64 Million | -278.15 Million |
| Debt repayment | -82.84 Million | -170 Million | -130 Million | -286.51 Million | -395.5 Million | -455 Million |
| Dividends payments | -338.45 Million | -282.12 Million | -220.64 Million | -170.34 Million | -86.98 Million | -105.35 Million |
| Common Stock Repurchased | -786.93 Thousand | -4.25 Million | -189.26 Million | -12.08 Million | -114.92 Million | -88.63 Million |
| Common Stock Issuance | - | 4.25 Million | 189.26 Million | 12.08 Million | 114.92 Million | - |
| Other Financing Activities | -11.29 Million | 85.74 Million | 122.88 Million | 159.42 Million | 216.16 Million | 282.19 Million |
| Accounts receivables | -43.43 Million | -76.4 Million | 235.66 Million | -70.52 Million | -108.6 Million | 44.62 Million |
| Accounts payables | 197.69 Million | 477.76 Million | 261.39 Million | 194.99 Million | 136.85 Million | -6.68 Million |
| Inventory | 26.9 Million | -58.19 Million | -105.69 Million | -44.51 Million | 36.78 Million | 41.27 Million |
| Other working capital | 14.07 Million | -33.58 Million | -16.51 Million | -19.07 Million | -4.23 Million | 42.21 Million |
| Cash at beginning of period | 1.17 Billion | 801.24 Million | 732.31 Million | 576.21 Million | 615.93 Million | 339.57 Million |
| Cash at end of period | 1.49 Billion | 1.17 Billion | 801.24 Million | 732.31 Million | 576.21 Million | 615.93 Million |
| Capital Expenditure | -21.19 Million | -26.99 Million | -76.9 Million | -71.82 Million | -59.03 Million | -52.14 Million |
| Effect of forex changes on cash | -2374.14 | 35.98 Thousand | -26.69 Thousand | -95.19 Thousand | 14.71 Thousand | 102.2 Thousand |
| Net cash flow / Change in cash | 310.98 Million | 378.04 Million | 68.92 Million | 156.1 Million | -39.72 Million | 276.36 Million |
| Free Cash Flow | 792.23 Million | 807.91 Million | 768.77 Million | 378.7 Million | 391.11 Million | 384.1 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 160.84 Million | 222.65 Million | 190.37 Million | 101.92 Million | 568.11 Million | 149.2 Million |
| Depreciation & Amortization | - | 19.05 Million | 19.05 Million | 77.62 Million | 77.62 Million | -37.7 Million |
| Deferred income taxes | - | - | - | - | -23.09 Million | 66.77 Million |
| Stock-based compensation | - | 4.1 Million | - | 14.07 Million | 14.07 Million | -8.52 Million |
| Change in working capital | - | -174.69 Million | - | -2.46 Million | 158.06 Million | -22.61 Million |
| Other non-cash items | -100.06 Million | 42.35 Million | -145.47 Million | 127.65 Million | 6.37 Million | -31.61 Million |
| Investing Cash Flow | -8.43 Million | -551.88 Million | -57.44 Million | -43.56 Million | -229.7 Million | -207.42 Million |
| Investments in PPE | -16.76 Million | -10.4 Million | -6.44 Million | -10.24 Million | -21.19 Million | -2.1 Million |
| Acquisitions | - | 15 Thousand | - | 10 Million | 10.15 Million | 0.42 |
| Investment purchases | 1.09 Billion | -1.1 Billion | - | -10 Million | -30.05 Million | -20 Million |
| Sales/Maturities of investments | 18.93 Million | 513.49 Million | - | 9.47 Million | 21.39 Million | 2.07 Million |
| Other Investing Activities | -10.6 Million | 50.99 Million | -50.99 Million | -42.79 Million | -210 Million | -187.39 Million |
| Financing Cash Flow | -5.46 Million | -433.45 Million | -11.46 Million | 11.28 Million | -272.73 Million | 3.49 Million |
| Debt repayment | -6.11 Million | -25.7 Million | -20 Million | -29.06 Million | -82.84 Million | -4.17 Million |
| Dividends payments | -1.16 Million | -449.81 Million | -20.66 Thousand | -338.45 Million | -338.45 Million | -102.22 Thousand |
| Common Stock Repurchased | 13.8 Thousand | -13.8 Thousand | - | -786.93 Thousand | -786.93 Thousand | 214 Thousand |
| Common Stock Issuance | - | - | - | - | - | -4.38 Million |
| Other Financing Activities | -513.29 Thousand | -458.37 Million | 8.55 Million | -9.72 Million | -11.29 Million | 11.93 Million |
| Accounts receivables | - | -206.52 Million | - | -43.43 Million | -43.43 Million | 8.32 Million |
| Accounts payables | - | - | - | - | 197.69 Million | 8.52 Million |
| Inventory | - | 27.72 Million | - | 26.9 Million | 26.9 Million | -30.94 Million |
| Other working capital | - | 4.1 Million | - | 14.07 Million | 14.07 Million | -8.52 Million |
| Cash at beginning of period | 726.89 Million | 1.46 Billion | 1.49 Billion | 1.21 Billion | 1.17 Billion | 1.3 Billion |
| Cash at end of period | 772.43 Million | 726.89 Million | 1.46 Billion | 1.49 Billion | 1.49 Billion | 1.21 Billion |
| Capital Expenditure | -16.76 Million | -10.4 Million | -6.44 Million | -10.24 Million | -21.19 Million | -2.1 Million |
| Effect of forex changes on cash | -5258.90 | 1463.43 | 694.05 | -8225.30 | -2374.14 | -15.68 Thousand |
| Net cash flow / Change in cash | 45.53 Million | -739.38 Million | -23.99 Million | 272.44 Million | 310.98 Million | -88.42 Million |
| Free Cash Flow | 44 Million | 235.55 Million | 38.46 Million | 294.49 Million | 792.23 Million | 113.4 Million |
HWM
KDDL
CTRRF
OBDC
3537
KMP